Industry Research Reports

Home > Reports > Chemical & Material > Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-24

Pages: 80 Pages

Report ld: 4209534

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Shingles Vaccine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Shingles Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Shingles Vaccine by region & country, by Type, and by Application.

The Shingles Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shingles Vaccine.

MARKET SEGMENTATION

By Company

Merck
GlaxoSmithKline

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Zostavax
Shingrix

Segment by Application

Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Shingles Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Shingles Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Shingles Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Shingles Vaccine Product Introduction

1.2 Global Shingles Vaccine Market Size Forecast

1.2.1 Global Shingles Vaccine Sales Value (2020-2031)

1.2.2 Global Shingles Vaccine Sales Volume (2020-2031)

1.2.3 Global Shingles Vaccine Sales Price (2020-2031)

1.3 Shingles Vaccine Market Trends & Drivers

1.3.1 Shingles Vaccine Industry Trends

1.3.2 Shingles Vaccine Market Drivers & Opportunity

1.3.3 Shingles Vaccine Market Challenges

1.3.4 Shingles Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Shingles Vaccine Players Revenue Ranking (2024)

2.2 Global Shingles Vaccine Revenue by Company (2020-2025)

2.3 Global Shingles Vaccine Players Sales Volume Ranking (2024)

2.4 Global Shingles Vaccine Sales Volume by Company Players (2020-2025)

2.5 Global Shingles Vaccine Average Price by Company (2020-2025)

2.6 Key Manufacturers Shingles Vaccine Manufacturing Base and Headquarters

2.7 Key Manufacturers Shingles Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Shingles Vaccine

2.9 Shingles Vaccine Market Competitive Analysis

2.9.1 Shingles Vaccine Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Shingles Vaccine Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Vaccine as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Zostavax

3.1.2 Shingrix

3.2 Global Shingles Vaccine Sales Value by Type

3.2.1 Global Shingles Vaccine Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Shingles Vaccine Sales Value, by Type (2020-2031)

3.2.3 Global Shingles Vaccine Sales Value, by Type (%) (2020-2031)

3.3 Global Shingles Vaccine Sales Volume by Type

3.3.1 Global Shingles Vaccine Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Shingles Vaccine Sales Volume, by Type (2020-2031)

3.3.3 Global Shingles Vaccine Sales Volume, by Type (%) (2020-2031)

3.4 Global Shingles Vaccine Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Under 50 Years Old

4.1.2 50-60 Years Old

4.1.3 60-70 Years Old

4.1.4 Above 70 Years Old

4.2 Global Shingles Vaccine Sales Value by Application

4.2.1 Global Shingles Vaccine Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Shingles Vaccine Sales Value, by Application (2020-2031)

4.2.3 Global Shingles Vaccine Sales Value, by Application (%) (2020-2031)

4.3 Global Shingles Vaccine Sales Volume by Application

4.3.1 Global Shingles Vaccine Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Shingles Vaccine Sales Volume, by Application (2020-2031)

4.3.3 Global Shingles Vaccine Sales Volume, by Application (%) (2020-2031)

4.4 Global Shingles Vaccine Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Shingles Vaccine Sales Value by Region

5.1.1 Global Shingles Vaccine Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Shingles Vaccine Sales Value by Region (2020-2025)

5.1.3 Global Shingles Vaccine Sales Value by Region (2026-2031)

5.1.4 Global Shingles Vaccine Sales Value by Region (%), (2020-2031)

5.2 Global Shingles Vaccine Sales Volume by Region

5.2.1 Global Shingles Vaccine Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Shingles Vaccine Sales Volume by Region (2020-2025)

5.2.3 Global Shingles Vaccine Sales Volume by Region (2026-2031)

5.2.4 Global Shingles Vaccine Sales Volume by Region (%), (2020-2031)

5.3 Global Shingles Vaccine Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Shingles Vaccine Sales Value, 2020-2031

5.4.2 North America Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Shingles Vaccine Sales Value, 2020-2031

5.5.2 Europe Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Shingles Vaccine Sales Value, 2020-2031

5.6.2 Asia Pacific Shingles Vaccine Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Shingles Vaccine Sales Value, 2020-2031

5.7.2 South America Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Shingles Vaccine Sales Value, 2020-2031

5.8.2 Middle East & Africa Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Shingles Vaccine Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Shingles Vaccine Sales Value

6.2.1 Key Countries/Regions Shingles Vaccine Sales Value, 2020-2031

6.2.2 Key Countries/Regions Shingles Vaccine Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Shingles Vaccine Sales Value, 2020-2031

6.3.2 United States Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Shingles Vaccine Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Shingles Vaccine Sales Value, 2020-2031

6.4.2 Europe Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Shingles Vaccine Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Shingles Vaccine Sales Value, 2020-2031

6.5.2 China Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

6.5.3 China Shingles Vaccine Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Shingles Vaccine Sales Value, 2020-2031

6.6.2 Japan Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Shingles Vaccine Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Shingles Vaccine Sales Value, 2020-2031

6.7.2 South Korea Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Shingles Vaccine Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Shingles Vaccine Sales Value, 2020-2031

6.8.2 Southeast Asia Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Shingles Vaccine Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Shingles Vaccine Sales Value, 2020-2031

6.9.2 India Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

6.9.3 India Shingles Vaccine Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Merck Shingles Vaccine Product Offerings

7.1.5 Merck Recent Development

7.2 GlaxoSmithKline

7.2.1 GlaxoSmithKline Company Information

7.2.2 GlaxoSmithKline Introduction and Business Overview

7.2.3 GlaxoSmithKline Shingles Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 GlaxoSmithKline Shingles Vaccine Product Offerings

7.2.5 GlaxoSmithKline Recent Development

8 Industry Chain Analysis

8.1 Shingles Vaccine Industrial Chain

8.2 Shingles Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Shingles Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Shingles Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Shingles Vaccine Market Trends

Table 2. Shingles Vaccine Market Drivers & Opportunity

Table 3. Shingles Vaccine Market Challenges

Table 4. Shingles Vaccine Market Restraints

Table 5. Global Shingles Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Shingles Vaccine Revenue Market Share by Company (2020-2025)

Table 7. Global Shingles Vaccine Sales Volume by Company (2020-2025) & (K Doses)

Table 8. Global Shingles Vaccine Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Shingles Vaccine Price by Company (2020-2025) & (USD/Dose)

Table 10. Key Manufacturers Shingles Vaccine Manufacturing Base and Headquarters

Table 11. Key Manufacturers Shingles Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Shingles Vaccine

Table 13. Global Shingles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Vaccine as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Shingles Vaccine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Shingles Vaccine Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Shingles Vaccine Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Shingles Vaccine Sales Market Share in Value by Type (2020-2025)

Table 20. Global Shingles Vaccine Sales Market Share in Value by Type (2026-2031)

Table 21. Global Shingles Vaccine Sales Volume by Type: 2020 VS 2024 VS 2031 (K Doses)

Table 22. Global Shingles Vaccine Sales Volume by Type (2020-2025) & (K Doses)

Table 23. Global Shingles Vaccine Sales Volume by Type (2026-2031) & (K Doses)

Table 24. Global Shingles Vaccine Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Shingles Vaccine Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Shingles Vaccine Price by Type (2020-2025) & (USD/Dose)

Table 27. Global Shingles Vaccine Price by Type (2026-2031) & (USD/Dose)

Table 28. Global Shingles Vaccine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Shingles Vaccine Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Shingles Vaccine Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Shingles Vaccine Sales Market Share in Value by Application (2020-2025)

Table 32. Global Shingles Vaccine Sales Market Share in Value by Application (2026-2031)

Table 33. Global Shingles Vaccine Sales Volume by Application: 2020 VS 2024 VS 2031 (K Doses)

Table 34. Global Shingles Vaccine Sales Volume by Application (2020-2025) & (K Doses)

Table 35. Global Shingles Vaccine Sales Volume by Application (2026-2031) & (K Doses)

Table 36. Global Shingles Vaccine Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Shingles Vaccine Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Shingles Vaccine Price by Application (2020-2025) & (USD/Dose)

Table 39. Global Shingles Vaccine Price by Application (2026-2031) & (USD/Dose)

Table 40. Global Shingles Vaccine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Shingles Vaccine Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Shingles Vaccine Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Shingles Vaccine Sales Value by Region (2020-2025) & (%)

Table 44. Global Shingles Vaccine Sales Value by Region (2026-2031) & (%)

Table 45. Global Shingles Vaccine Sales Volume by Region (K Doses): 2020 VS 2024 VS 2031

Table 46. Global Shingles Vaccine Sales Volume by Region (2020-2025) & (K Doses)

Table 47. Global Shingles Vaccine Sales Volume by Region (2026-2031) & (K Doses)

Table 48. Global Shingles Vaccine Sales Volume by Region (2020-2025) & (%)

Table 49. Global Shingles Vaccine Sales Volume by Region (2026-2031) & (%)

Table 50. Global Shingles Vaccine Average Price by Region (2020-2025) & (USD/Dose)

Table 51. Global Shingles Vaccine Average Price by Region (2026-2031) & (USD/Dose)

Table 52. Key Countries/Regions Shingles Vaccine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Shingles Vaccine Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Shingles Vaccine Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Shingles Vaccine Sales Volume, (2020-2025) & (K Doses)

Table 56. Key Countries/Regions Shingles Vaccine Sales Volume, (2026-2031) & (K Doses)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 60. Merck Shingles Vaccine Product Offerings

Table 61. Merck Recent Development

Table 62. GlaxoSmithKline Company Information

Table 63. GlaxoSmithKline Introduction and Business Overview

Table 64. GlaxoSmithKline Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 65. GlaxoSmithKline Shingles Vaccine Product Offerings

Table 66. GlaxoSmithKline Recent Development

Table 67. Key Raw Materials Lists

Table 68. Raw Materials Key Suppliers Lists

Table 69. Shingles Vaccine Downstream Customers

Table 70. Shingles Vaccine Distributors List

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. Shingles Vaccine Product Picture

Figure 2. Global Shingles Vaccine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Shingles Vaccine Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Shingles Vaccine Sales Volume (2020-2031) & (K Doses)

Figure 5. Global Shingles Vaccine Sales Price (2020-2031) & (USD/Dose)

Figure 6. Shingles Vaccine Report Years Considered

Figure 7. Global Shingles Vaccine Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Shingles Vaccine Players Sales Volume Ranking (2024) & (K Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Shingles Vaccine Revenue in 2024

Figure 10. Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Zostavax Picture

Figure 12. Shingrix Picture

Figure 13. Global Shingles Vaccine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Shingles Vaccine Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Shingles Vaccine Sales Volume by Type (2020 VS 2024 VS 2031) & (K Doses)

Figure 16. Global Shingles Vaccine Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Shingles Vaccine Price by Type (2020-2031) & (USD/Dose)

Figure 18. Product Picture of Under 50 Years Old

Figure 19. Product Picture of 50-60 Years Old

Figure 20. Product Picture of 60-70 Years Old

Figure 21. Product Picture of Above 70 Years Old

Figure 22. Global Shingles Vaccine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Shingles Vaccine Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Shingles Vaccine Sales Volume by Application (2020 VS 2024 VS 2031) & (K Doses)

Figure 25. Global Shingles Vaccine Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Shingles Vaccine Price by Application (2020-2031) & (USD/Dose)

Figure 27. North America Shingles Vaccine Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Shingles Vaccine Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Shingles Vaccine Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Shingles Vaccine Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Shingles Vaccine Sales Volume (%), (2020-2031)

Figure 39. United States Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Shingles Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Shingles Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 45. China Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 47. China Shingles Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Shingles Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Shingles Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Shingles Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 57. India Shingles Vaccine Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Shingles Vaccine Sales Value by Type (%), 2024 VS 2031

Figure 59. India Shingles Vaccine Sales Value by Application (%), 2024 VS 2031

Figure 60. Shingles Vaccine Industrial Chain

Figure 61. Shingles Vaccine Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Shingles Vaccine market? zhanKai

The top companies in the global Shingles Vaccine market are Merck、GlaxoSmithKline.

Related Reports

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 118
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2026
The global Shingles Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 122
USD 2900.00
(Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 129
USD 4900.00
(Single User License)
Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Shingles Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 65
USD 4250.00
(Single User License)
Global Shingles Vaccine Market Research Report 2025
The global market for Shingles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 81
USD 2900.00
(Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-19
Pages: 72
USD 4900.00
(Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 84
USD 2900.00
(Single User License)

Shingles Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Shingles Vaccine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 118
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2026
The global Shingles Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 122
USD 2900.00 (Single User License)
Global Shingles Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 129
USD 4900.00 (Single User License)
Global Shingles Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Shingles Vaccine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 65
USD 4250.00 (Single User License)
Global Shingles Vaccine Market Research Report 2025
The global market for Shingles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 81
USD 2900.00 (Single User License)
Global Shingles Vaccine Market Insights, Forecast to 2030
The global Shingles Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-19
Pages: 72
USD 4900.00 (Single User License)
Shingles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Shingles Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Shingles Vaccine Market Research Report 2024
The global Shingles Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 84
USD 2900.00 (Single User License)